FXYD2 and neoplasm: In addition, FXYD2 expression level was significantly higher in advanced-stage disease (stage 3 and 4; mean: 2.9869, n = 24) compared with early tumor stages (stage 1 and 2; mean: 0.8358, n = 22, P = 0.0121, Figure 1E).